Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
1675201-14-5O=C(CC=Cc1cc(F)c(F)cc1F)N1CCn2c(nnc2C(F)(F)F)C1BLDAVCZELRQXFP-UHFFFAOYSA-N1675201-14-5Verwenden1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-3-buten-1-one is a derivative of Sitagliptin(S491000) which is a trizolopyrazine dipeptidyl peptidase IV inhibitor. Sitagliptin has recently been approved for the therapy of type II diabetes.